Crossmark

The de novo CACNA1A pathogenic variant Y1384C associated with hemiplegic migraine, early onset cerebellar atrophy and developmental delay leads to a loss of Cav2.1 channel function

Crossref DOI link: https://doi.org/10.1186/s13041-021-00745-2

Published Online: 2021-02-08

Published Print: 2021-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Gandini, Maria A.

Souza, Ivana A.

Ferron, Laurent

Innes, A. Micheil

Zamponi, Gerald W. https://orcid.org/0000-0002-0644-9066
Funding

Funding for this research was provided by:

Canadian Institutes of Health Research

Canada Excellence Research Chairs, Government of Canada
License Information

Text and Data Mining valid from 2021-02-08

Version of Record valid from 2021-02-08
More Information

Article History

Received: 23 December 2020

Accepted: 2 February 2021

First Online: 8 February 2021

Ethics approval and consent to participate

: Not applicable.

: Not applicable.

: The authors declare no competing interest.

Document is current

Any future updates will be listed below